Intellectual Property
Jan. 24, 2018
Rivals clash over prenatal test patent claims in closing arguments
An attorney representing Ariosa Diagnostics Inc. told a federal jury Tuesday that his client is not infringing a rival’s patents on prenatal tests that detect genetic defects.
SAN FRANCISCO — An attorney representing Ariosa Diagnostics Inc. told a federal jury Tuesday that his client is not infringing a rival’s patents on prenatal tests that detect genetic defects.
“This is not a case about patent infringement,” said David Gindler, a partner with Irell & Manella LLP who represents the San Jose company. “We have our technology and they have theirs.”
Edward Reines, a R...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In